Table 2 Docking binding energy of 10 targets and budesonide.

From: Exploring the molecular mechanism of budesonide enteric capsules in the treatment of IgA nephropathy based on bioinformatics

No

Target

PDB ID

Binding Energy / (kcal/mol)

A

IL-6

1ALU

 − 8.84

B

ALB

8RGK

 − 10.99

C

TNF

7JRA

 − 10.13

D

AKT1

4GV1

 − 10.36

E

IL-1β

6Y8I

 − 9.38

F

TP53

1UOL

 − 8.46

G

MMP-9

6ESM

 − 15.00

H

CASP3

1RE1

 − 8.51

I

TGF-β1

5VQP

 − 13.4

J

PTGS2

5F19

 − 13.06